NCT07475351 Comparison of Bone-patellar Tendon-bone and Patellar Tendon-bone Grafts in ACL Reconstruction
| NCT ID | NCT07475351 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de Granada |
| Condition | Anterior Cruciate Ligament (ACL) Reconstruction |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2026-01-01 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this randomized study is to compare donor site morbidity and clinical and functional outcomes of both surgery techniques (bone-patellar tendon-bone (BPTB) graft versus bone-patellar tendon without patellar bone plug (PT) graft) for anterior cruciate ligament reconstruction (ACLR) in athletes. The main questions it aims to answer are: * Does PT graft reduce donor site morbidity compared to the standard BPTB graft? * Does PT technique provide clinical and functional results comparable to the BPTB technique? Researchers will compare the incidence of complications and clinical and functional outcomes between the BPTB and PT grafts groups. Patients will: * Undergo ACLR surgical intervention using one of the two assigned techniques (BPTB or PT) * Follow a two-year assessment program, including visits at three, eight, 12 and 24 months after surgery.
Eligibility Criteria
Inclusion Criteria: * Time for injury to surgery of less than six months. * Active athletes (federated or recreational) * Patellar tendon length \> 42mm measured by MRI. * Age between 12 and 40 years old * Genders eligible for Study: both Exclusion Criteria: * Previous surgery or history of ligamentous knee injuries. * Concomitant knee ligament injury * Major meniscal injury (more than 50% of the lateral or medial meniscus) * Chondral injury greater than Outerbridge Grade I-II
Contact & Investigator
Manuel Arroyo-Morales
STUDY CHAIR
Universidad de Granada
Frequently Asked Questions
Who can join the NCT07475351 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 40 Years, studying Anterior Cruciate Ligament (ACL) Reconstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07475351 currently recruiting?
Yes, NCT07475351 is actively recruiting participants. Contact the research team at josemariard@ugr.es for enrollment information.
Where is the NCT07475351 trial being conducted?
This trial is being conducted at Granada, Spain.
Who is sponsoring the NCT07475351 clinical trial?
NCT07475351 is sponsored by Universidad de Granada. The principal investigator is Manuel Arroyo-Morales at Universidad de Granada. The trial plans to enroll 110 participants.